Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
about
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next StepOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisHistone deacetylase inhibitor induces the expression of select epithelial genes in mouse utricle sensory epithelia-derived progenitor cells.Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways.Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.The epigenetics of epithelial-mesenchymal plasticity in cancer.Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells.A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells.The role of alveolar epithelium in radiation-induced lung injuryCurcumin inhibits cobalt chloride-induced epithelial-to-mesenchymal transition associated with interference with TGF-β/Smad signaling in hepatocytes.The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro StudyRNA polymerase II pausing can be retained or acquired during activation of genes involved in the epithelial to mesenchymal transition.A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.Trichostatin A Inhibits Epithelial Mesenchymal Transition Induced by TGF-β1 in Airway EpitheliumTrichostatin A attenuates ventilation-augmented epithelial-mesenchymal transition in mice with bleomycin-induced acute lung injury by suppressing the Akt pathway.Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinomap300 is elevated in systemic sclerosis and its expression is positively regulated by TGF-β: epigenetic feed-forward amplification of fibrosis.Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.PAI-1 in tissue fibrosis.The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis.Molecular basis of organ fibrosis: potential therapeutic approaches.Targeted therapy of epigenomic regulatory mechanisms controlling the epithelial to mesenchymal transition during tumor progression.Epithelial Plasticity in Cancer: Unmasking a MicroRNA Network for TGF-β-, Notch-, and Wnt-Mediated EMT.Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells.Loss of histone deacetylases 1 and 2 in hepatocytes impairs murine liver regeneration through Ki67 depletion.Association of histone acetylation at the ACTA2 promoter region with epithelial mesenchymal transition of lens epithelial cells.LncRNA ANCR down-regulation promotes TGF-β-induced EMT and metastasis in breast cancer.Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis.MicroRNA-26b functions as a proapoptotic factor in porcine follicular Granulosa cells by targeting Sma-and Mad-related protein 4.Trichostatin A inhibits radiation-induced epithelial-to-mesenchymal transition in the alveolar epithelial cells.Trichostatin A ameliorates renal tubulointerstitial fibrosis through modulation of the JNK-dependent Notch-2 signaling pathway.Soluble Dietary Fiber Ameliorates Radiation-Induced Intestinal Epithelial-to-Mesenchymal Transition and Fibrosis.MicroRNA-155 attenuates activation of hepatic stellate cell by simultaneously preventing EMT process and ERK1 signalling pathway.Panobinostat suppresses the mesenchymal phenotype in a novel claudin-low triple negative patient-derived breast cancer model.[Research advance on mechanism and application of HATs and HDACs in epithelial-mesenchymal transition of lung cancer].Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjectsEpigenetic Regulation of Myofibroblast Phenotypes in Fibrosis
P2860
Q26771518-7DE86473-A2D5-491D-985D-16C6F11E09A1Q28075646-0D50E1D1-CE47-4201-8B48-96235DBFBFA3Q30405625-4809DDB7-2558-45BC-9B82-3F53C65E69F7Q33612064-3732DC9B-CCEA-48A5-8DFB-A6B40DE8E0DAQ34101036-FAC0C4DD-8757-4BEC-84F4-F53B201DD7F8Q34310378-251D769D-048F-4956-8DF6-9B07186397A4Q34432569-4630A66E-F9DB-46A0-9FD1-A7B3181DD74BQ34516513-03A3AC08-B4F6-4983-834F-9075B17B2E45Q34551617-9B18D1F9-F13E-4A2F-A80A-B6A79C80B749Q34672530-DC6C70C4-871F-4BEE-9CAA-CB89097E315FQ35194528-F7B9493A-3C72-43D4-BAB9-69AA186AA9CAQ35562114-9532F963-6D45-4250-8E65-FDB3CD573D89Q35883829-2410A654-4122-46C7-B967-33BC883E1836Q36115999-2089CC20-33F4-4108-9C02-86BD93409F04Q36289784-BF138CF7-2219-4FFD-8773-038A8FFB9E8FQ36400910-26BEA0B0-6F62-4CD0-9374-DCEB7F626D56Q36767089-E64D2C39-6A91-457F-91D9-F4ABFE1B4281Q37399295-074C3ABC-DEB7-45BE-AECC-82757971A07DQ37638268-E0C6C5FC-442E-48B7-BBF8-B1264AB70AE1Q37861626-E74A1C3A-75A9-4206-8C92-7A00DF94C844Q38021684-01049A0F-DDD0-412E-B90C-B6FA1F2FDD71Q38121751-5F228475-8C3C-48BA-92DA-B74A99AA89E8Q38212160-D3539CFE-5D03-4586-B9D7-6EB6B425CBB2Q38425500-C33B8FA2-7B6C-4994-8DA6-133897539483Q38855904-85355C73-89DB-4B84-87E8-C71934B60EA8Q39033577-8692BB78-B400-49CA-A5E9-E502357C9AC1Q39142767-771A2F46-B712-48CE-9D00-E9ACE3260994Q41869409-F970DBE2-D04F-40A3-B381-6E3E22EA7DEFQ42366546-BCBE3AEF-28E5-48F5-8DCE-25BEDFA208D1Q42369863-80E18050-9408-4CDA-9EB0-57A4419FB786Q44784192-C5793EC3-4D38-482A-94D3-82A66C636D28Q47109093-F8F60C83-10C0-48B9-8242-451E3E20EDBAQ47131483-99536255-6A34-416F-9618-89D0DFD7B98FQ50219354-0A8A3825-C17C-498E-9CDB-32BA300F20E1Q54328253-BF54DE3C-9BB8-40FC-9622-8508954C120AQ55007506-C3063B37-E013-4A46-8574-DDC48148742DQ55465384-68D9317C-6EEB-4C7A-913F-69F4A2C03D5FQ56981583-CE135139-01CB-4F7F-BAA6-6A2CB3130F48Q57147732-8C78A8FF-DD03-4B91-A0DB-DE10457BF774
P2860
Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Histone deacetylase inhibition ...... mal transition in hepatocytes.
@en
Histone deacetylase inhibition ...... mal transition in hepatocytes.
@nl
type
label
Histone deacetylase inhibition ...... mal transition in hepatocytes.
@en
Histone deacetylase inhibition ...... mal transition in hepatocytes.
@nl
prefLabel
Histone deacetylase inhibition ...... mal transition in hepatocytes.
@en
Histone deacetylase inhibition ...... mal transition in hepatocytes.
@nl
P2093
P2860
P356
P1433
P1476
Histone deacetylase inhibition ...... mal transition in hepatocytes.
@en
P2093
Aki Kaimori
Ayman A Koteish
Esteban Mezey
James J Potter
Michael Choti
P2860
P304
P356
10.1002/HEP.23765
P407
P577
2010-09-01T00:00:00Z